|
|
Volumn 337, Issue , 2008, Pages
|
|
GlaxoSmithKline to limit payments it makes to US doctors to $150,000 a year.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG INDUSTRY;
ECONOMICS;
FINANCIAL MANAGEMENT;
NOTE;
PHYSICIAN;
UNITED STATES;
DRUG INDUSTRY;
PHYSICIANS;
RESEARCH SUPPORT AS TOPIC;
UNITED STATES;
|
|
EID: 56249092816
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.a2315 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
